FindTrial
Sign In

Study to Understand the effects of Telmisartan and Metoprolol Combination Tablets in Indian Patients with High Blood Pressure

A Retrospective, Observational, Multicentric Study Targeted to assess the Effectiveness, Tolerability and Preferred Patient Profile for Fixed Dose Combination of Telmisartan and Metoprolol in Indian Patients with Hypertension (TARGET BETA-2 Study) - Target Beta-2

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/01/100848
Enrollment
10000
Registered
2026-01-12
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10-I16- Hypertensive diseases

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

Torrent Pharmaceuticals Ltd.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients who were prescribed FDC of Telmisartan and Metoprolol XR (any dosage)

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
1. Change in SBP and DBPTimepoint: Baseline and Post 30 days—

Secondary

MeasureTime frame
1. Change in heart rate in patients with and without tachycardia.Timepoint: Baseline and Post 30 days;1. Patient profile and time taken (in years) to switchover to dual therapy from monotherapy. 2. Proportion of na ve hypertensives, started with dual therapy.Timepoint: Baseline—

Countries

India

Contacts

Public ContactNarendra Chouksey

Torrent Pharmaceuticals Ltd.

LokeshRV@torrentpharma.com917069000601

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026